Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tanshinone IIA inhibits neuronal ferroptosis and relieves cerebral ischemia‒reperfusion injury by regulating miR-449a/ACSL4. | Metab Brain Dis | 2025 | 40542896 | PubTator, text mining | PubMed |
| Mechanism of LINC00958 in ferroptosis of breast cancer through the SRSF1/GPX4 axis. | Hereditas | 2025 | 40537877 | PubTator, text mining | PubMed |
| Exposure of polystyrene nanoplastics led to ferroptosis on cardiomyocytes. | Environ Pollut | 2025 | 40532809 | PubTator, text mining | PubMed |
| Weifuchun ( ) exerts therapeutic effects on gastric fundic gland polyps by promoting ferroptosis. | J Tradit Chin Med | 2025 | 40524300 | PubTator, text mining | PubMed |
| Quercetin-loaded exosomes delivery system prevents myopia progression by targeting endoplasmic reticulum stress and ferroptosis in scleral fibroblasts. | Mater Today Bio | 2025 | 40520556 | PubTator, text mining | PubMed |
| 1,25(OH)2D3 ameliorates DSS-induced intestinal ferroptosis through the SIRT3-SOD2-mtROS pathway. | J Nutr Biochem | 2025 | 40513839 | PubTator, text mining | PubMed |
| Klotho promotes bone formation in rheumatoid arthritis-associated osteoporosis by modulating the Fgf23/Fgfr1/NF-κB pathway and inhibiting ferroptosis. | Mol Immunol | 2025 | 40513341 | PubTator, text mining | PubMed |
| Targeting programmed cell death with natural products: a potential therapeutic strategy for diminished ovarian reserve and fertility preservation. | Front Pharmacol | 2025 | 40510420 | PubTator, text mining | PubMed |
| The Splice Variant of the NCOR2 Gene BQ323636.1 Modulates ACSL4 Expression to Enhance Fatty Acid Metabolism and Support of Tumor Growth in Breast Cancer. | Int J Mol Sci | 2025 | 40507798 | PubTator, text mining | PubMed |
| ACSL4 knockdown inhibits colorectal cancer progression through stimulating anti-tumor immunity. | Neoplasia | 2025 | 40505269 | PubTator, text mining | PubMed |
| Metabolic reprogramming in hepatocellular carcinoma: an integrated omics study of lipid pathways and their diagnostic potential. | J Transl Med | 2025 | 40500772 | PubTator, text mining | PubMed |
| The advancement of ubiquitination regulation in apoptosis, ferroptosis, autophagy, drug resistance and treatment of cancer. | Arch Biochem Biophys | 2025 | 40499632 | PubTator, text mining | PubMed |
| Deciphering mitochondrial dysfunction in keratoconus: Insights into ACSL4 from machine learning-based bulk and single-cell transcriptome analyses and experimental validation. | Comput Struct Biotechnol J | 2025 | 40496889 | PubTator, text mining | PubMed |
| Empagliflozin ameliorates RSL3-induced ferroptosis in vascular endothelial cells via the NRF2/HO-1 pathway. | BMC Cardiovasc Disord | 2025 | 40483457 | PubTator, text mining | PubMed |
| Dynamic regulators of ferroptosis: Post-translational modifications in ferroptotic cell death. | Pharmacol Res | 2025 | 40482689 | PubTator, text mining | PubMed |
| Endothelial cell iron overload and ferroptosis mediate thrombosis and inflammation through the miR-32-5p/neurofibromin 2 pathway. | Eur J Med Res | 2025 | 40481609 | PubTator, text mining | PubMed |
| Pro-ferroptotic lipids as key control points for caveola formation and disassembly. | Cell Rep | 2025 | 40478736 | PubTator, text mining | PubMed |
| Plasma fibronectin alleviate acrolein-induced ferroptosis via AMPK/Nrf2 pathway in HUVEC. | Food Chem Toxicol | 2025 | 40472920 | PubTator, text mining | PubMed |
| Erigoster B targeting DECR1 induces ferroptosis of breast cancer cells via promoting phosphatidylcholine/arachidonic acid metabolism. | NPJ Precis Oncol | 2025 | 40467779 | PubTator, text mining | PubMed |
| Hyperoside improves intestinal mucosal immunity against zearalenone-induced intestinal barrier damage by regulating intestinal flora. | Vet Immunol Immunopathol | 2025 | 40446714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=40